| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
176,759 |
152,550 |
$15.64M |
| 99283 |
|
98,891 |
91,765 |
$15.25M |
| 99284 |
|
73,970 |
68,592 |
$11.77M |
| 99214 |
|
93,367 |
83,373 |
$10.18M |
| 90791 |
|
13,842 |
12,300 |
$9.64M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
103,613 |
88,593 |
$6.96M |
| 90832 |
|
46,972 |
31,515 |
$6.50M |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
160,952 |
20,567 |
$6.24M |
| 99282 |
|
33,871 |
32,364 |
$5.77M |
| G0378 |
Hospital observation service, per hour |
3,223 |
3,180 |
$3.71M |
| S9485 |
Crisis intervention mental health services, per diem |
3,125 |
2,560 |
$3.53M |
| 90834 |
|
15,788 |
10,045 |
$3.04M |
| 99212 |
|
34,574 |
30,466 |
$2.42M |
| 36415 |
|
233,164 |
148,626 |
$2.20M |
| 99204 |
|
12,583 |
12,310 |
$2.12M |
| 99203 |
|
16,115 |
15,751 |
$1.98M |
| 99285 |
|
9,985 |
9,641 |
$1.98M |
| 99211 |
|
113,271 |
96,687 |
$1.97M |
| 99215 |
Prolong outpt/office vis |
12,305 |
11,645 |
$1.87M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
10,310 |
1,447 |
$1.85M |
| 80307 |
|
38,773 |
24,850 |
$1.81M |
| 70450 |
|
10,659 |
10,225 |
$1.65M |
| 99391 |
|
25,296 |
22,220 |
$1.50M |
| D0999 |
|
9,318 |
9,011 |
$1.49M |
| 92012 |
|
16,553 |
14,698 |
$1.36M |
| 92014 |
|
12,506 |
11,550 |
$1.32M |
| D9999 |
|
8,244 |
7,748 |
$1.18M |
| 99205 |
Prolong outpt/office vis |
5,194 |
5,034 |
$1.10M |
| 99392 |
|
22,589 |
22,352 |
$1.09M |
| 96361 |
|
10,430 |
9,822 |
$1.08M |
| 80053 |
|
94,475 |
87,796 |
$1.06M |
| 99442 |
|
19,907 |
18,120 |
$997K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46,307 |
40,149 |
$993K |
| 90853 |
|
14,408 |
3,834 |
$979K |
| 93306 |
|
5,936 |
5,788 |
$933K |
| 81408 |
|
694 |
678 |
$881K |
| 77336 |
|
3,463 |
740 |
$874K |
| 87635 |
|
20,945 |
19,440 |
$802K |
| 74177 |
|
5,606 |
5,303 |
$775K |
| 77067 |
|
6,829 |
6,788 |
$752K |
| 81420 |
|
1,149 |
1,119 |
$745K |
| J9271 |
Injection, pembrolizumab, 1 mg |
93 |
76 |
$745K |
| 90460 |
|
40,542 |
40,346 |
$725K |
| 96372 |
|
40,386 |
32,840 |
$690K |
| 99202 |
|
6,926 |
6,801 |
$669K |
| 76816 |
|
7,308 |
6,661 |
$660K |
| 86480 |
|
10,609 |
10,283 |
$651K |
| 87491 |
|
22,633 |
21,815 |
$640K |
| 96365 |
|
8,409 |
7,975 |
$628K |
| 81220 |
|
1,333 |
1,300 |
$592K |
| 80061 |
|
50,833 |
50,035 |
$568K |
| 90935 |
|
3,195 |
291 |
$542K |
| 90792 |
|
2,250 |
2,193 |
$525K |
| 93005 |
|
41,701 |
37,950 |
$519K |
| 95808 |
|
803 |
799 |
$489K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
2,424 |
2,269 |
$469K |
| 71046 |
|
33,096 |
32,089 |
$439K |
| 99441 |
|
13,332 |
11,807 |
$422K |
| 83036 |
|
56,847 |
55,607 |
$420K |
| 99393 |
|
14,764 |
14,641 |
$419K |
| 99443 |
|
4,965 |
4,735 |
$408K |
| 85027 |
|
110,023 |
101,647 |
$406K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
5,282 |
301 |
$390K |
| 77386 |
|
1,725 |
184 |
$387K |
| D7140 |
|
13,606 |
10,059 |
$382K |
| 96360 |
|
4,340 |
4,263 |
$382K |
| 90461 |
|
14,948 |
14,890 |
$381K |
| 76811 |
|
2,084 |
2,058 |
$335K |
| D0330 |
|
15,835 |
15,041 |
$335K |
| 70486 |
|
2,139 |
2,086 |
$331K |
| 72125 |
|
2,721 |
2,606 |
$328K |
| 90677 |
|
2,467 |
2,463 |
$325K |
| GZ3ZZZZ |
|
137 |
15 |
$322K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,756 |
6,702 |
$320K |
| 90471 |
|
36,052 |
35,364 |
$319K |
| 97110 |
|
8,544 |
3,853 |
$317K |
| 86703 |
|
22,615 |
22,221 |
$312K |
| 86360 |
|
6,560 |
6,337 |
$306K |
| 99394 |
|
10,751 |
10,580 |
$306K |
| J0401 |
Injection, aripiprazole (abilify maintena), 1 mg |
1,214 |
1,178 |
$301K |
| 86850 |
|
17,800 |
16,254 |
$298K |
| 92004 |
|
2,067 |
2,007 |
$291K |
| 59025 |
|
3,076 |
2,332 |
$278K |
| 45378 |
|
347 |
342 |
$266K |
| 84443 |
|
23,093 |
22,500 |
$257K |
| 96413 |
|
1,974 |
1,038 |
$255K |
| 90750 |
|
2,792 |
2,757 |
$252K |
| 77063 |
|
5,141 |
5,060 |
$248K |
| D0140 |
|
16,917 |
15,439 |
$245K |
| 86359 |
|
6,545 |
6,323 |
$245K |
| 96110 |
|
4,487 |
4,411 |
$244K |
| 76819 |
|
3,206 |
2,910 |
$232K |
| 99051 |
|
19,510 |
13,578 |
$231K |
| 96374 |
|
11,425 |
10,892 |
$226K |
| 88305 |
|
2,932 |
2,722 |
$226K |
| 87535 |
|
6,363 |
6,142 |
$224K |
| 12011 |
|
1,034 |
992 |
$222K |
| 82948 |
|
44,382 |
34,337 |
$219K |
| 87637 |
|
4,345 |
4,292 |
$219K |
| 94640 |
|
7,764 |
7,215 |
$216K |
| 82306 |
|
8,260 |
8,119 |
$212K |
| 99201 |
|
2,173 |
2,101 |
$207K |
| 45380 |
|
283 |
282 |
$206K |
| 77290 |
|
778 |
272 |
$206K |
| 80048 |
|
20,039 |
19,331 |
$198K |
| 87591 |
|
8,725 |
8,457 |
$196K |
| 12001 |
|
828 |
801 |
$194K |
| 76830 |
|
2,961 |
2,835 |
$194K |
| 0002A |
|
6,443 |
6,420 |
$193K |
| 76856 |
|
1,173 |
1,161 |
$189K |
| 93010 |
|
27,443 |
23,305 |
$183K |
| 0001A |
|
6,620 |
6,602 |
$181K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
2,150 |
613 |
$180K |
| 86901 |
|
17,970 |
16,306 |
$177K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
2,226 |
2,201 |
$173K |
| 76818 |
|
1,739 |
1,025 |
$172K |
| 76770 |
|
1,303 |
1,275 |
$170K |
| 97530 |
|
4,445 |
2,464 |
$169K |
| 90715 |
|
8,030 |
7,969 |
$169K |
| 71260 |
|
880 |
864 |
$169K |
| 71275 |
|
674 |
665 |
$156K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
295 |
214 |
$153K |
| 81329 |
|
1,277 |
1,231 |
$150K |
| 86803 |
|
14,728 |
14,454 |
$149K |
| 96366 |
|
2,076 |
1,924 |
$149K |
| 76641 |
|
1,168 |
1,018 |
$147K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
2,523 |
1,815 |
$144K |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
4,334 |
4,079 |
$144K |
| 86900 |
|
17,954 |
16,290 |
$142K |
| 83655 |
|
13,722 |
13,549 |
$140K |
| 99401 |
|
2,296 |
2,241 |
$139K |
| 97162 |
|
1,374 |
1,365 |
$135K |
| 10060 |
|
720 |
663 |
$132K |
| 73610 |
|
6,367 |
5,555 |
$132K |
| 87633 |
|
836 |
831 |
$131K |
| 81161 |
|
670 |
653 |
$128K |
| 90686 |
|
12,980 |
12,897 |
$127K |
| 95807 |
|
282 |
282 |
$121K |
| 87798 |
|
4,408 |
4,293 |
$119K |
| 76805 |
|
904 |
852 |
$118K |
| 90697 |
|
1,987 |
1,986 |
$118K |
| 99395 |
|
2,945 |
2,875 |
$114K |
| 81405 |
|
596 |
583 |
$111K |
| 77065 |
Tomosynthesis, mammo |
951 |
874 |
$111K |
| 29580 |
|
1,433 |
415 |
$107K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
1,686 |
628 |
$107K |
| J2794 |
Injection, risperidone (risperdal consta), 0.5 mg |
263 |
166 |
$103K |
| 96375 |
|
10,365 |
9,236 |
$102K |
| 76705 |
|
1,991 |
1,913 |
$101K |
| 73630 |
|
5,165 |
4,732 |
$100K |
| 92133 |
|
2,228 |
2,164 |
$99K |
| 82805 |
|
11,013 |
9,971 |
$98K |
| 90651 |
|
1,997 |
1,992 |
$97K |
| 73564 |
|
3,711 |
3,561 |
$97K |
| 77066 |
Tomosynthesis, mammo |
600 |
597 |
$96K |
| 87340 |
|
13,385 |
13,050 |
$96K |
| 73130 |
|
5,051 |
4,326 |
$96K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
2,606 |
2,389 |
$95K |
| 11900 |
|
637 |
625 |
$95K |
| 97802 |
|
2,037 |
2,024 |
$95K |
| 0004A |
|
2,535 |
2,525 |
$94K |
| 90732 |
|
902 |
873 |
$92K |
| 90833 |
|
1,372 |
1,159 |
$92K |
| 81001 |
|
43,628 |
39,597 |
$90K |
| 99381 |
|
2,940 |
2,901 |
$86K |
| 76536 |
|
911 |
891 |
$86K |
| 71250 |
|
420 |
415 |
$86K |
| 74176 |
|
633 |
627 |
$85K |
| 81361 |
|
743 |
726 |
$85K |
| 87624 |
|
2,494 |
2,435 |
$85K |
| 86780 |
|
7,977 |
7,451 |
$84K |
| 73110 |
|
4,307 |
3,601 |
$84K |
| 86003 |
|
1,631 |
1,416 |
$81K |
| 73030 |
|
4,218 |
3,791 |
$80K |
| 97112 |
|
2,515 |
1,429 |
$78K |
| 70551 |
|
209 |
206 |
$78K |
| 86706 |
|
10,238 |
9,985 |
$78K |
| 45385 |
|
142 |
141 |
$77K |
| 82728 |
|
7,213 |
7,114 |
$76K |
| 77412 |
|
390 |
51 |
$76K |
| 76817 |
|
973 |
784 |
$76K |
| 86769 |
|
2,631 |
2,546 |
$75K |
| 90472 |
|
8,218 |
8,098 |
$75K |
| J1944 |
Injection, aripiprazole lauroxil, (aristada), 1 mg |
404 |
392 |
$73K |
| 76801 |
|
607 |
587 |
$73K |
| 84153 |
|
4,737 |
4,641 |
$73K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
4,827 |
4,408 |
$72K |
| 96127 |
|
25,204 |
23,806 |
$71K |
| 84439 |
|
10,242 |
9,955 |
$71K |
| 90999 |
|
380 |
66 |
$70K |
| 20610 |
|
555 |
520 |
$69K |
| 93970 |
|
303 |
301 |
$69K |
| 12002 |
|
295 |
281 |
$68K |
| D7210 |
|
1,772 |
1,486 |
$68K |
| 92523 |
|
293 |
292 |
$66K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,611 |
6,363 |
$66K |
| 90734 |
|
1,636 |
1,630 |
$66K |
| 92557 |
|
1,455 |
1,344 |
$65K |
| 77062 |
|
407 |
405 |
$64K |
| 72100 |
|
2,227 |
2,173 |
$64K |
| 85610 |
|
20,696 |
18,321 |
$64K |
| 83880 |
|
4,528 |
4,375 |
$64K |
| 90670 |
|
4,151 |
4,133 |
$63K |
| 90836 |
|
638 |
423 |
$63K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
63 |
63 |
$62K |
| 81243 |
|
1,417 |
1,333 |
$62K |
| 96567 |
|
102 |
32 |
$61K |
| 73590 |
|
3,727 |
3,393 |
$61K |
| 81401 |
|
691 |
675 |
$60K |
| D0120 |
|
6,483 |
6,109 |
$60K |
| 93247 |
|
298 |
297 |
$60K |
| 94060 |
|
828 |
727 |
$59K |
| H0050 |
Alcohol and/or drug services, brief intervention, per 15 minutes |
1,089 |
1,022 |
$59K |
| 71045 |
|
7,023 |
6,425 |
$58K |
| 77061 |
|
423 |
420 |
$57K |
| 93971 |
|
993 |
971 |
$56K |
| 84702 |
|
12,409 |
11,210 |
$55K |
| 88142 |
|
2,429 |
2,317 |
$55K |
| 83970 |
|
1,712 |
1,673 |
$55K |
| 83020 |
|
4,411 |
4,287 |
$55K |
| H0038 |
Self-help/peer services, per 15 minutes |
2,005 |
1,639 |
$55K |
| H2001 |
Rehabilitation program, per 1/2 day |
498 |
109 |
$54K |
| 76813 |
|
772 |
744 |
$53K |
| 90746 |
|
936 |
930 |
$52K |
| 86704 |
|
6,483 |
6,349 |
$52K |
| 73562 |
|
2,528 |
2,224 |
$52K |
| 73560 |
|
1,874 |
1,591 |
$51K |
| 87522 |
Neg quan hep c or qual rna |
1,218 |
1,198 |
$49K |
| 99384 |
|
636 |
631 |
$49K |
| H2010 |
Comprehensive medication services, per 15 minutes |
746 |
685 |
$49K |
| 76642 |
|
560 |
552 |
$49K |
| 83550 |
|
8,084 |
7,972 |
$48K |
| 87086 |
|
12,757 |
12,017 |
$48K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
38 |
27 |
$48K |
| 96367 |
|
1,745 |
1,403 |
$48K |
| 81257 |
|
716 |
699 |
$48K |
| 81025 |
|
12,641 |
12,130 |
$47K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
169 |
103 |
$46K |
| 73502 |
|
1,884 |
1,762 |
$46K |
| 92567 |
|
1,795 |
1,782 |
$46K |
| 99402 |
|
621 |
608 |
$45K |
| 99383 |
|
592 |
585 |
$45K |
| H2011 |
Crisis intervention service, per 15 minutes |
236 |
196 |
$44K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,238 |
1,197 |
$44K |
| 73140 |
|
2,095 |
1,877 |
$44K |
| 76700 |
|
238 |
236 |
$43K |
| 94726 |
|
644 |
641 |
$43K |
| 86762 |
|
3,397 |
3,289 |
$43K |
| 92134 |
|
889 |
850 |
$42K |
| 87631 |
|
998 |
989 |
$42K |
| H0001 |
Alcohol and/or drug assessment |
216 |
194 |
$40K |
| 86765 |
|
3,400 |
3,283 |
$39K |
| 82607 |
|
3,334 |
3,267 |
$39K |
| 76870 |
|
548 |
535 |
$38K |
| 83540 |
|
8,199 |
8,079 |
$38K |
| 99291 |
|
192 |
189 |
$38K |
| 84703 |
|
11,467 |
11,137 |
$38K |
| 78452 |
|
153 |
94 |
$37K |
| 97161 |
|
480 |
471 |
$37K |
| 0072A |
|
935 |
934 |
$36K |
| 90620 |
|
1,297 |
1,276 |
$36K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,163 |
1,052 |
$36K |
| 93303 |
|
164 |
163 |
$36K |
| D1120 |
|
4,539 |
4,529 |
$35K |
| 90846 |
|
390 |
383 |
$35K |
| 80076 |
|
5,948 |
5,866 |
$35K |
| 86593 |
|
10,507 |
10,275 |
$34K |
| D1110 |
|
2,672 |
2,667 |
$34K |
| 86787 |
|
3,319 |
3,208 |
$34K |
| 86735 |
|
3,177 |
3,077 |
$34K |
| 66984 |
|
51 |
51 |
$34K |
| 0071A |
|
972 |
970 |
$34K |
| D7240 |
|
346 |
174 |
$33K |
| 97165 |
|
323 |
322 |
$32K |
| 85730 |
|
14,234 |
13,693 |
$32K |
| 70553 |
|
80 |
80 |
$32K |
| 77263 |
|
110 |
31 |
$32K |
| 86141 |
|
4,118 |
3,971 |
$31K |
| 92083 |
|
569 |
480 |
$30K |
| 96137 |
|
448 |
347 |
$30K |
| 86708 |
|
3,851 |
3,771 |
$30K |
| 95816 |
|
81 |
81 |
$29K |
| 90674 |
|
1,714 |
1,703 |
$29K |
| 73552 |
|
1,664 |
1,549 |
$29K |
| 87536 |
|
305 |
297 |
$29K |
| 97803 |
|
758 |
755 |
$29K |
| 43239 |
|
49 |
48 |
$28K |
| 81400 |
|
688 |
672 |
$28K |
| 76815 |
|
469 |
451 |
$28K |
| 82274 |
|
2,341 |
2,328 |
$28K |
| 91320 |
|
550 |
549 |
$28K |
| 81255 |
|
704 |
687 |
$28K |
| J2680 |
Injection, fluphenazine decanoate, up to 25 mg |
1,204 |
834 |
$27K |
| 93975 |
|
112 |
112 |
$27K |
| 70498 |
|
109 |
108 |
$27K |
| 94729 |
|
467 |
465 |
$27K |
| 87651 |
|
1,373 |
1,361 |
$27K |
| 82043 |
|
5,719 |
5,594 |
$27K |
| 99382 |
|
347 |
347 |
$27K |
| 73090 |
|
2,161 |
1,951 |
$26K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,667 |
436 |
$26K |
| 81251 |
|
705 |
688 |
$25K |
| 81200 |
|
703 |
686 |
$25K |
| 82951 |
|
2,100 |
1,980 |
$25K |
| 92250 |
|
667 |
640 |
$25K |
| D0150 |
|
2,465 |
2,290 |
$24K |
| 73620 |
|
796 |
745 |
$24K |
| 82105 |
|
1,773 |
1,713 |
$24K |
| 86709 |
|
3,443 |
3,366 |
$24K |
| D9223 |
|
552 |
548 |
$23K |
| 0124A |
|
565 |
564 |
$23K |
| 92579 |
|
417 |
416 |
$23K |
| 76000 |
|
221 |
219 |
$23K |
| 99245 |
|
126 |
126 |
$22K |
| 72070 |
|
679 |
671 |
$22K |
| 59425 |
|
740 |
667 |
$22K |
| 80320 |
|
6,822 |
6,527 |
$22K |
| 73080 |
|
1,442 |
1,271 |
$21K |
| 81260 |
|
702 |
686 |
$21K |
| 90480 |
|
636 |
635 |
$21K |
| 90716 |
|
1,831 |
1,825 |
$21K |
| 90707 |
|
1,698 |
1,692 |
$21K |
| 90633 |
|
2,525 |
2,517 |
$20K |
| H0049 |
Alcohol and/or drug screening |
387 |
363 |
$20K |
| 97166 |
|
204 |
204 |
$20K |
| 84146 |
|
1,082 |
1,045 |
$19K |
| 36430 |
|
93 |
82 |
$19K |
| 97010 |
|
2,838 |
1,525 |
$19K |
| 93308 |
|
258 |
251 |
$19K |
| 73700 |
|
88 |
80 |
$19K |
| 82785 |
|
1,324 |
1,298 |
$19K |
| 99396 |
|
183 |
172 |
$19K |
| 96161 |
|
3,215 |
3,055 |
$19K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
7,360 |
7,104 |
$18K |
| 84403 |
|
724 |
662 |
$18K |
| 0011A |
|
1,243 |
1,232 |
$18K |
| 67028 |
|
204 |
120 |
$18K |
| D9222 |
|
820 |
809 |
$18K |
| 87486 |
|
853 |
847 |
$18K |
| 86580 |
|
3,331 |
3,246 |
$17K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
13 |
12 |
$17K |
| 71271 |
|
84 |
83 |
$17K |
| 90681 |
|
2,349 |
2,345 |
$17K |
| 83001 |
|
939 |
893 |
$17K |
| 92555 |
|
375 |
374 |
$17K |
| 93017 |
|
279 |
276 |
$16K |
| 97140 |
|
562 |
349 |
$16K |
| D0274 |
|
2,760 |
2,747 |
$16K |
| 88175 |
|
560 |
557 |
$16K |
| 85007 |
|
7,045 |
6,619 |
$15K |
| D2392 |
|
615 |
533 |
$15K |
| 85025 |
|
5,815 |
5,494 |
$15K |
| 86160 |
|
940 |
813 |
$15K |
| 81003 |
|
5,618 |
4,725 |
$15K |
| 99385 |
|
208 |
204 |
$15K |
| 90656 |
|
1,254 |
1,254 |
$14K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,172 |
2,054 |
$14K |
| 77080 |
|
503 |
495 |
$14K |
| 84484 |
|
10,875 |
9,678 |
$14K |
| D7230 |
|
207 |
148 |
$14K |
| 85045 |
|
4,901 |
4,672 |
$14K |
| 73060 |
|
1,198 |
1,097 |
$14K |
| 87581 |
|
853 |
847 |
$14K |
| 83735 |
|
7,426 |
6,969 |
$14K |
| 92002 |
|
168 |
163 |
$14K |
| 99408 |
|
289 |
216 |
$14K |
| 83002 |
|
779 |
737 |
$14K |
| 87081 |
|
2,957 |
2,903 |
$14K |
| 90698 |
|
2,105 |
2,103 |
$14K |
| 90694 |
|
539 |
536 |
$14K |
| 96158 |
|
239 |
179 |
$14K |
| D1208 |
|
3,597 |
3,589 |
$13K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
13 |
12 |
$13K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
68 |
64 |
$13K |
| 76820 |
|
303 |
148 |
$13K |
| 80165 |
|
1,453 |
1,404 |
$13K |
| 36416 |
|
658 |
629 |
$12K |
| 86592 |
|
3,896 |
3,575 |
$12K |
| 84207 |
|
448 |
446 |
$12K |
| G2067 |
Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
227 |
89 |
$12K |
| 93246 |
|
293 |
291 |
$12K |
| 83615 |
|
3,036 |
2,894 |
$11K |
| D1206 |
|
2,520 |
2,516 |
$11K |
| 96040 |
|
189 |
179 |
$11K |
| 82570 |
|
2,953 |
2,825 |
$11K |
| 72170 |
|
724 |
702 |
$11K |
| D0220 |
|
2,978 |
2,954 |
$11K |
| 86008 |
|
110 |
91 |
$11K |
| 59430 |
|
50 |
50 |
$11K |
| 87186 |
|
3,168 |
3,052 |
$11K |
| 82947 |
|
1,572 |
1,352 |
$11K |
| 72190 |
|
613 |
603 |
$11K |
| 72141 |
|
25 |
24 |
$11K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
10,956 |
8,891 |
$10K |
| 84100 |
|
5,967 |
5,677 |
$10K |
| 52000 |
|
12 |
12 |
$10K |
| 78815 |
|
13 |
13 |
$10K |
| 99412 |
|
183 |
55 |
$10K |
| 54161 |
|
14 |
13 |
$9K |
| 85651 |
|
3,669 |
3,545 |
$9K |
| 31575 |
|
75 |
74 |
$9K |
| 92015 |
|
427 |
422 |
$9K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
29 |
25 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
1,243 |
1,031 |
$9K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,425 |
1,184 |
$9K |
| 77334 |
|
50 |
40 |
$9K |
| 93976 |
|
59 |
59 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,353 |
8,578 |
$9K |
| 87538 |
|
258 |
253 |
$8K |
| 93320 |
|
160 |
159 |
$8K |
| 95810 |
|
14 |
14 |
$8K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
172 |
170 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,037 |
11,305 |
$8K |
| D9995 |
|
341 |
317 |
$8K |
| 86225 |
|
829 |
807 |
$8K |
| 73070 |
|
715 |
655 |
$8K |
| 90648 |
|
1,386 |
1,382 |
$8K |
| 73120 |
|
371 |
335 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18,388 |
17,115 |
$8K |
| 0081A |
|
178 |
178 |
$8K |
| 90744 |
|
951 |
950 |
$8K |
| 99281 |
|
356 |
353 |
$8K |
| 86038 |
|
921 |
907 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
4,382 |
4,132 |
$8K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
41 |
38 |
$8K |
| 87636 |
|
486 |
463 |
$7K |
| 90653 |
|
278 |
278 |
$7K |
| 70491 |
|
25 |
24 |
$7K |
| 83516 |
|
542 |
508 |
$7K |
| 31231 |
|
36 |
36 |
$7K |
| 96415 |
|
33 |
24 |
$7K |
| D2391 |
|
454 |
358 |
$7K |
| 70496 |
|
39 |
38 |
$7K |
| 84425 |
|
393 |
388 |
$7K |
| 90661 |
|
538 |
538 |
$7K |
| 84156 |
|
2,336 |
2,219 |
$7K |
| 92551 |
|
5,216 |
5,214 |
$7K |
| 87088 |
|
912 |
886 |
$7K |
| 84436 |
|
1,680 |
1,636 |
$7K |
| 77300 |
|
62 |
60 |
$6K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
3,373 |
2,976 |
$6K |
| 84445 |
|
138 |
133 |
$6K |
| 87502 |
|
235 |
234 |
$6K |
| 93325 |
|
210 |
206 |
$6K |
| 86376 |
|
457 |
449 |
$6K |
| 82803 |
|
2,326 |
2,085 |
$6K |
| 90723 |
|
998 |
994 |
$6K |
| 76814 |
|
283 |
267 |
$6K |
| H0033 |
Oral medication administration, direct observation |
140 |
112 |
$6K |
| 85018 |
|
2,372 |
2,371 |
$6K |
| D9239 |
|
179 |
176 |
$6K |
| 0012A |
|
278 |
278 |
$6K |
| G0390 |
Trauma response team associated with hospital critical care service |
127 |
125 |
$6K |
| 96900 |
|
202 |
66 |
$5K |
| 83690 |
|
7,988 |
7,494 |
$5K |
| 73600 |
|
278 |
261 |
$5K |
| 86235 |
|
132 |
113 |
$5K |
| 0082A |
|
117 |
117 |
$5K |
| 84134 |
|
459 |
454 |
$5K |
| D0272 |
|
1,910 |
1,904 |
$5K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
60 |
12 |
$5K |
| 87338 |
|
452 |
450 |
$5K |
| 97168 |
|
71 |
69 |
$5K |
| 67228 |
|
15 |
12 |
$5K |
| 92558 |
|
269 |
268 |
$5K |
| 88304 |
|
167 |
163 |
$5K |
| 87800 |
|
193 |
193 |
$5K |
| 95004 |
|
50 |
50 |
$5K |
| 87070 |
|
1,337 |
1,248 |
$5K |
| 87517 |
|
102 |
100 |
$5K |
| 72197 |
|
12 |
12 |
$4K |
| 77427 |
|
22 |
12 |
$4K |
| 99406 |
|
405 |
391 |
$4K |
| 96910 |
|
41 |
13 |
$4K |
| 96376 |
|
2,068 |
1,898 |
$4K |
| 92504 |
|
110 |
106 |
$4K |
| 90736 |
|
32 |
32 |
$4K |
| D0603 |
|
1,319 |
1,241 |
$4K |
| 99386 |
|
39 |
39 |
$4K |
| 97116 |
|
151 |
83 |
$4K |
| 99173 |
|
4,791 |
4,789 |
$4K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
67 |
62 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,057 |
1,920 |
$4K |
| 82652 |
|
102 |
99 |
$4K |
| 72131 |
|
26 |
26 |
$4K |
| 84590 |
|
345 |
342 |
$4K |
| 82248 |
|
1,016 |
925 |
$4K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
14 |
14 |
$4K |
| 82784 |
|
235 |
154 |
$4K |
| 96368 |
|
326 |
283 |
$3K |
| 87390 |
|
507 |
501 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,514 |
5,065 |
$3K |
| 96380 |
|
200 |
200 |
$3K |
| 90696 |
|
516 |
516 |
$3K |
| 83021 |
|
527 |
527 |
$3K |
| J1741 |
Injection, ibuprofen, 100 mg |
917 |
915 |
$3K |
| D9243 |
|
64 |
64 |
$3K |
| 84235 |
|
54 |
53 |
$3K |
| 96136 |
|
39 |
38 |
$3K |
| 96156 |
|
36 |
36 |
$3K |
| 84550 |
|
1,185 |
1,096 |
$3K |
| 90710 |
|
333 |
333 |
$3K |
| 82670 |
|
117 |
110 |
$3K |
| 82550 |
|
1,597 |
1,533 |
$3K |
| 86689 |
|
505 |
499 |
$3K |
| 93351 |
|
13 |
13 |
$3K |
| 74019 |
|
121 |
119 |
$3K |
| 86696 |
|
221 |
208 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,847 |
5,636 |
$3K |
| 87205 |
|
1,630 |
1,450 |
$3K |
| 41800 |
|
27 |
24 |
$3K |
| 0074A |
|
71 |
71 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,587 |
7,630 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
662 |
649 |
$3K |
| 96402 |
|
75 |
74 |
$3K |
| 82677 |
|
112 |
111 |
$3K |
| D9430 |
|
199 |
162 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,668 |
3,758 |
$3K |
| 86334 |
|
147 |
119 |
$2K |
| 90739 |
|
17 |
17 |
$2K |
| 72040 |
|
82 |
82 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,944 |
3,548 |
$2K |
| 86695 |
|
223 |
209 |
$2K |
| D2740 |
|
33 |
28 |
$2K |
| Q0084 |
Chemotherapy administration by infusion technique only, per visit |
17 |
12 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,566 |
3,337 |
$2K |
| 87071 |
|
609 |
604 |
$2K |
| 80178 |
|
348 |
324 |
$2K |
| 74018 |
|
97 |
94 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
12 |
12 |
$2K |
| 82977 |
|
448 |
431 |
$2K |
| 1159F |
|
16,360 |
9,690 |
$2K |
| 83605 |
|
1,163 |
1,108 |
$2K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
2,786 |
2,603 |
$2K |
| D9110 |
|
223 |
213 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
708 |
406 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,955 |
1,863 |
$2K |
| 84402 |
|
85 |
83 |
$2K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,749 |
1,316 |
$2K |
| 83883 |
|
126 |
68 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,442 |
6,170 |
$2K |
| 85379 |
|
1,311 |
1,296 |
$2K |
| 90717 |
|
13 |
13 |
$2K |
| 86140 |
|
621 |
594 |
$2K |
| 76885 |
|
13 |
13 |
$2K |
| 82375 |
|
698 |
667 |
$2K |
| 74246 |
|
12 |
12 |
$2K |
| 87661 |
|
59 |
58 |
$2K |
| 99242 |
|
43 |
39 |
$2K |
| D0230 |
|
652 |
650 |
$2K |
| 12013 |
|
13 |
13 |
$2K |
| 82010 |
|
1,882 |
1,644 |
$2K |
| 90700 |
|
219 |
218 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
9,151 |
7,771 |
$2K |
| 73000 |
|
92 |
88 |
$2K |
| 82330 |
|
1,130 |
1,081 |
$2K |
| 86923 |
|
77 |
67 |
$2K |
| 72128 |
|
13 |
13 |
$2K |
| 84165 |
|
212 |
160 |
$2K |
| 70360 |
|
86 |
83 |
$2K |
| 99429 |
|
125 |
109 |
$2K |
| 74022 |
|
99 |
98 |
$2K |
| 87184 |
|
270 |
268 |
$2K |
| 86336 |
|
111 |
110 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
370 |
312 |
$1K |
| 82810 |
|
698 |
667 |
$1K |
| 71100 |
|
152 |
142 |
$1K |
| 82746 |
|
144 |
139 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
1,867 |
1,321 |
$1K |
| 96160 |
|
150 |
143 |
$1K |
| 11721 |
|
32 |
29 |
$1K |
| 87521 |
Neg quan hep c or qual rna |
44 |
42 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,641 |
2,077 |
$1K |
| 84480 |
|
138 |
131 |
$1K |
| 58300 |
|
12 |
12 |
$1K |
| 92235 |
|
12 |
12 |
$1K |
| 85384 |
|
495 |
420 |
$1K |
| 90691 |
|
15 |
15 |
$1K |
| 72081 |
|
29 |
29 |
$1K |
| 82962 |
|
1,116 |
1,045 |
$1K |
| 71048 |
|
72 |
71 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
458 |
434 |
$1K |
| 76775 |
|
75 |
63 |
$1K |
| 86800 |
|
81 |
79 |
$1K |
| 0154A |
|
35 |
35 |
$1K |
| 86255 |
|
143 |
137 |
$1K |
| 80354 |
|
2,251 |
1,930 |
$1K |
| 86320 |
|
42 |
38 |
$1K |
| 73660 |
|
94 |
89 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
621 |
426 |
$1K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,121 |
1,115 |
$1K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,261 |
2,990 |
$1K |
| 90662 |
|
60 |
60 |
$1K |
| 3075F |
|
19,590 |
17,427 |
$1K |
| 87040 |
|
488 |
438 |
$1K |
| 84704 |
|
67 |
66 |
$962.70 |
| 82247 |
|
200 |
165 |
$948.01 |
| 86430 |
|
188 |
184 |
$909.69 |
| 94760 |
|
1,459 |
1,421 |
$903.50 |
| 80348 |
|
87 |
70 |
$886.87 |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,776 |
2,408 |
$878.82 |
| 88312 |
|
13 |
13 |
$855.04 |
| 0502F |
|
203 |
166 |
$849.74 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,022 |
2,778 |
$803.50 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
6,838 |
6,004 |
$788.66 |
| 76857 |
|
12 |
12 |
$786.36 |
| D0170 |
|
121 |
113 |
$757.56 |
| D1351 |
|
81 |
29 |
$750.75 |
| 87593 |
|
20 |
19 |
$744.36 |
| D0210 |
|
91 |
91 |
$740.42 |
| 83050 |
|
698 |
667 |
$739.84 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
628 |
608 |
$734.65 |
| 98960 |
|
22 |
20 |
$728.15 |
| 82952 |
|
163 |
156 |
$725.88 |
| 82627 |
|
33 |
29 |
$695.10 |
| 80164 |
|
69 |
68 |
$676.46 |
| S0190 |
Mifepristone, oral, 200 mg |
12 |
12 |
$667.56 |
| 73100 |
|
26 |
26 |
$626.84 |
| 82533 |
|
39 |
37 |
$607.19 |
| 90713 |
|
54 |
54 |
$603.66 |
| J2060 |
Injection, lorazepam, 2 mg |
1,985 |
1,767 |
$589.12 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
250 |
244 |
$582.00 |
| 86705 |
|
74 |
69 |
$537.83 |
| 0003A |
|
13 |
13 |
$520.80 |
| 0031A |
|
12 |
12 |
$519.91 |
| 88300 |
|
49 |
48 |
$517.54 |
| 82950 |
|
93 |
93 |
$515.91 |
| D3330 |
|
13 |
13 |
$514.50 |
| 99451 |
|
14 |
14 |
$511.68 |
| 84479 |
|
121 |
121 |
$509.16 |
| J3411 |
Injection, thiamine hcl, 100 mg |
660 |
607 |
$464.08 |
| 94761 |
|
683 |
668 |
$442.63 |
| 74021 |
|
17 |
17 |
$434.79 |
| J9035 |
Injection, bevacizumab, 10 mg |
16 |
12 |
$417.15 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
464 |
460 |
$407.05 |
| 81015 |
|
172 |
164 |
$393.93 |
| 82164 |
|
27 |
24 |
$392.22 |
| 82955 |
|
41 |
41 |
$387.03 |
| 73521 |
|
13 |
13 |
$382.04 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
13 |
13 |
$358.36 |
| 95851 |
|
14 |
14 |
$350.65 |
| 83498 |
|
14 |
13 |
$350.52 |
| V2632 |
Posterior chamber intraocular lens |
27 |
27 |
$349.47 |
| D9990 |
|
30 |
27 |
$341.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
132 |
123 |
$338.23 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
222 |
186 |
$333.27 |
| 85041 |
|
298 |
298 |
$325.93 |
| 82042 |
|
15 |
15 |
$325.69 |
| 51798 |
|
13 |
12 |
$295.89 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,003 |
1,781 |
$289.38 |
| 82397 |
|
67 |
66 |
$280.93 |
| 90381 |
|
51 |
51 |
$278.99 |
| 85652 |
|
159 |
155 |
$276.90 |
| 85060 |
|
14 |
14 |
$254.82 |
| 11720 |
|
14 |
12 |
$253.95 |
| 90611 |
|
224 |
223 |
$251.81 |
| 85014 |
|
299 |
299 |
$242.29 |
| 83010 |
|
39 |
37 |
$232.92 |
| 80329 |
|
51 |
49 |
$225.48 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
110 |
108 |
$211.10 |
| 85240 |
|
13 |
12 |
$204.52 |
| D0270 |
|
52 |
51 |
$198.88 |
| 87147 |
|
37 |
37 |
$195.20 |
| D9310 |
|
53 |
53 |
$194.50 |
| D0602 |
|
234 |
231 |
$192.47 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
26 |
25 |
$173.12 |
| J1756 |
Injection, iron sucrose, 1 mg |
41 |
12 |
$171.42 |
| 90685 |
|
204 |
204 |
$169.15 |
| D0601 |
|
435 |
431 |
$157.86 |
| 84520 |
|
115 |
100 |
$141.52 |
| 84154 |
|
12 |
12 |
$134.25 |
| 84155 |
|
34 |
33 |
$123.95 |
| D0190 |
|
824 |
821 |
$97.57 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
43 |
39 |
$96.32 |
| G0008 |
Administration of influenza virus vaccine |
227 |
227 |
$92.96 |
| 87899 |
|
25 |
14 |
$87.11 |
| 82565 |
|
46 |
46 |
$81.31 |
| D9219 |
|
22 |
20 |
$77.54 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
81 |
66 |
$72.40 |
| 84132 |
|
42 |
42 |
$60.28 |
| 87804 |
|
17 |
16 |
$59.87 |
| 82465 |
|
14 |
12 |
$58.27 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
42 |
39 |
$56.43 |
| 81002 |
|
21 |
21 |
$56.16 |
| 82310 |
|
14 |
14 |
$50.99 |
| 90380 |
|
12 |
12 |
$50.20 |
| S0028 |
Injection, famotidine, 20 mg |
92 |
90 |
$49.11 |
| 82435 |
|
39 |
39 |
$46.40 |
| D9420 |
|
33 |
30 |
$45.74 |
| 84295 |
|
39 |
39 |
$41.82 |
| 82150 |
|
33 |
33 |
$38.56 |
| 87210 |
|
13 |
13 |
$35.89 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
49 |
49 |
$28.54 |
| 3078F |
|
62,006 |
48,759 |
$28.07 |
| 87075 |
|
29 |
28 |
$19.89 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
26 |
24 |
$16.51 |
| J1940 |
Injection, furosemide, up to 20 mg |
19 |
12 |
$14.53 |
| 88720 |
|
160 |
145 |
$11.97 |
| 3074F |
|
53,499 |
42,652 |
$8.49 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
43 |
43 |
$8.21 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
14 |
14 |
$8.02 |
| 3079F |
|
20,669 |
17,881 |
$7.78 |
| 87880 |
|
31 |
31 |
$3.75 |
| J3480 |
Injection, potassium chloride, per 2 meq |
16 |
13 |
$3.50 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
14 |
12 |
$1.71 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
26 |
26 |
$1.04 |
| 3077F |
|
16,149 |
12,791 |
$0.53 |
| 1160F |
|
11,295 |
8,153 |
$0.30 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
25 |
25 |
$0.08 |
| D1330 |
|
818 |
818 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
26 |
26 |
$0.00 |
| 3080F |
|
6,081 |
5,124 |
$0.00 |
| 3044F |
|
154 |
154 |
$0.00 |
| 1220F |
|
1,455 |
1,454 |
$0.00 |
| 80050 |
|
479 |
478 |
$0.00 |
| 44388 |
|
35 |
35 |
$0.00 |
| 0241U |
|
12 |
12 |
$0.00 |
| 71020 |
|
27 |
26 |
$0.00 |
| D1310 |
|
90 |
90 |
$0.00 |
| 99080 |
|
4,150 |
935 |
$0.00 |
| 99499 |
|
5,546 |
4,132 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
212 |
203 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
50 |
50 |
$0.00 |
| 48510 |
|
14 |
14 |
$0.00 |
| 3725F |
|
15 |
15 |
$0.00 |
| 2022F |
|
28 |
28 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
56 |
56 |
$0.00 |